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Abstract 
Immunological stimulation frat mucosal type mast ceils (line RBL-2H3) by clustering the type I Fc, receptor (Fc,RI) causes a fast and transient 
tyrosine phosphorylation of several proteins. This implied the involvement of both, protein tyrosine kinases (PTKs) and protein tyrosine phosphatases 
(PTPases) in that process. Inorder to identify the PTPases involved in these very early steps coupling Fc,RI stimulus to cell response, we undertook 
the purification and characterization of PTPases present in RBL-2H3 cells. In one of the ceils' membranal fractions, a PTPase activity was found 
to be enhanced 2- to 3-fold upon cell stimulation by Fc~RI clustering. Characterization of this activity implies its involvement i  control of the Fc,RI 
signalling cascade. 
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1. Introduction 
Protein tyrosine phosphorylation is a key element in 
cellular signal transduction cascades and is therefore a
highly regulated process [1-3]. It is controlled by the 
specific action of protein tyrosine kinases (PTKs) and 
protein tyrosine phosphatases (PTPases), [1,4,5]. While 
the diverse types of PTKs have been extensively charac- 
terized for their regulation mechanisms and physiologi- 
cal substrates, considerably less is known about these 
aspects pertinent to PTPases. Two distinct general fami- 
lies of PTPases have so far been identified: cytosolic and 
transmembranal. One of the better studied PTPases is 
the transmembranal CD45 [6,7], a hematopoietic-cell 
specific molecule [8,9]. CD45 is apparently essential for 
the very early signalling events generated via the T-cell 
receptor [10-12]. It has been shown that CD45 dephos- 
phorylates the carboxy-terminal phosphotyrosine 
(Tyr 5°5) of the PTK lck - a member of the src-family and 
thereby activates it [13]. 
CD45 has also been shown to activate by 
dephosphorylation a other member of the src-family; 
fyn, also involved in the signal transduction of T-cells 
[14]. This suggested an activating function of CD45 and 
positions it at one of the earliest steps in the stimulus- 
response coupling cascade of T-cells. However, it is still 
unknown how the activity of CD45 is regulated. It has 
been shown that it undergoes phosphorylation on tyro- 
sine residues by an unknown PTK upon T-cell stimula- 
tion [15] yet no influence of this modification on the 
CD45 PTPase activity could be established. Recently, a 
decrease in the CD45 PTPase activity was reported upon 
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increasing intracellular free Ca2+-ion concentration, in- 
duced by ionomycin [15]. 
Mast cells serve as a paradigm for investigating immu- 
nological stimulus-response coupling cascades initiated 
by clustering antigen receptors, e.g. the type 1 Fc recep- 
tor for IgE (Fc,RI). This immunological stimulation 
leads to the association of the src-family member PTKs 
lyn or yes with the Fc,RI and their activation [16]. As a 
consequence, several cellular proteins undergo transient 
phosphorylation f their tyrosine residues. Among these 
are two of the Fc~RI subunits namely the fl- and ~,-chains 
[17] phospholipase C~,I (PLC~,I) [18,19] and a 72-kDa 
protein (pp72) [20,21] that has been recently identified to 
be the tyrosine kinase p72 ~yk [22]. This phosphorylation 
is very transient and depends on Fc,RI clustering as its 
abrogation by addition of an excess of monovalent 
hapten was found to accelerate rapid dephosphorylation 
of these proteins [17-19]. This indicates that these proc- 
esses are highly regulated and involve both the action of 
PTKs and PTPases. 
In order to try and resolve the PTPase(s) involved in 
the early Fc,RI signalling steps in mast cells we studied 
PTPase activities present in RBL-2H3 cells and report 
here the partial purification and characterization of a 
PTPase that exhibits marked activity enhancement upon 
Fc,RI clustering. 
2. Materials and methods 
2. I. Reagents and cell-culture media 
O-Phospho-L-tyrosine, O-phospho-L-serine, O-phospho-L-threonine, 
4-nitrophenyl phosphate (pNPP), Triton X-100, phenyl arsine oxide, 
sodium orthovanadate, phenylmethylsulfonyl fluoride (PMSF), le- 
upeptin, pepstatin and dithiotreitol were all obtained from Sigma 
Chemical Co. St. Louis, MO, USA. Powdered culture media s well as 
fetal calf serum were purchased from Gibco, Grand Island, NY, USA. 
Penicillin-streptomycin mixture was from Bit-lab, Jerusalem, Israel. 
DE-52 was from Whatman, Maidstone, Kent, UK. Thapsigargin was 
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obtained from Calbiochem Corp., La Jolla, CA, USA. Bovine serum 
albumin (BSA) was derivatized with an average of eleven 2,4 dinitro- 
phenyl residues (DNP I:BSA) in our laboratory from BSA (fraction V) 
(Sigma Chemical Co.) and 1-fluoro,2,4,-dinitrophenyl-benzene (DNP). 
DNP-specific IgE class mAb A 2 [25] was grown as ascites in mice. Rat 
mucosal mast cells, subline RBL-2H3 [26] were originally obtained 
from Dr. R. Siraganian (NIH, Betbesda, MD). They were maintained 
in Dulbecco's modified EAGLE's medium (DMEM), supplemented 
with 10% FCS, 2 mM glutamine and antibiotics in a humidified atmos- 
phere with 7% CO2 at 370C. Cells from confluent cultures were de- 
tached and harvested by incubation with 10 mM EDTA in medium for 
15 rain. 
2.2. Preparation of subcellular fractions 
RBL-2H3 cells (3 x l0 s) were detached and harvested as indicated 
above. The following procedure was carried out on ice, unless indicated 
otherwise: The cells were washed in cold Tyrode's buffer (130 mM 
NaCI, 5 mM KCI, 1.4 mM CaCI2, 1 mM MgC12, 5.6 mM glucose, 10 
mM HEPES, 0.1% BSA, pH 7.4) and were swollen by treatment with 
the hypotonic homogenization buffer (25 mM Tris, 2% glycerol, 2 mM 
DTT, 1 mM PMSF, 10/tg of aprotinin/ml, 1/~g of pepstatin/ml) at
3 x 10 s cells in 3 ml for 15 min. Following that, the ceils were homoge- 
nized by 40 strokes in a Dounce homogenizer. Nuclei and unbroken 
cells were removed by centrifugation (103x g, 5 rain, 40C). The super- 
natant was centrifuged (105 x g, 60 rain, 5°C) in order to separate the 
soluble fractions. The pellet was then treated with 3 ml of homogeniza- 
tion buffer to which Triton X-100 was added (1% final concentration). 
The resultant suspension was recentrifuged asbefore, but only for 20 
min. The supernatant was taken as membranal fraction. 
2.3. Partial purification of PTPases 
Cytosolic and membranal fractions were each fractionated on DE-52 
columns (2 ml volume in Bio-Rd Poly-Prep 0.8 x 4 cm columns) which 
were equilibrated in homogenization buffer. The cytosolic and mem- 
branal fractions were each loaded on the columns. The columns were 
washed with 2 ml homogenization buffer and proteins were then eluted 
by a step-wise increase in ionic strength of the eluting homogenization 
buffer (0.06, 0.12, 0.25 and 0.5 M NaCI). Three ml of each salt concen- 
tration were used and 1 ml fractions were collected. 
2.4. Assays for PTPase activity 
Each eluted fraction was assayed for its PTPase activity using, with 
some modifications the protocol originally described by Mustelin et al. 
[25]: Briefly, 50/,1 of the fraction and 50/al of the substrate (5 mM 
O-phosphotyrosine in 1 M sodium acetate, pH 6.0) were mixed and 
incubated for 30 min at 37°C. The reaction was stopped by addition 
of 150/zl of 25% (w/v) TCA and 50/ll BSA (10 mg/ml). The precipitated 
proteins were removed by centrifugation and the supernatants were 
used for measurement of the produced inorganic phosphate, To this end 
100/tl of the supernatant were transferred to 96-well microtiter plates 
and to each well 100/21 of Reagent C (1 vol of 6 N sulfuric acid, 1 vol 
of distilled water, 1 vol of 2,5% ammonium olybdate, 1vol of 10% 
ascorbic acid) were added, mixed well and incubated for 30 rain at 
37°C. The absorbance of this solution at 620 nm was measured against 
the blank by an ELISA plate reader. The control expressing the basal 
hydrolysis rate of the substrate contained 50/~1 of homogenization 
buffer instead of an eluted fraction. PTPase activity is presented as 
/amol inorganic phosphate produced per min per mg protein present in 
the sample. In some assays O-phosphothreonine or O-phosphoserine 
were employed as substrates u ing the same protocol. The basal hydrol- 
ysis values were for: O-phosphotyrosine 8x 10 -4 mM Pi/min, O- 
phosphoserine 5.8x10 -3 mM Pi/min and O-phosphothreonine 
2.4 x 10 -4 mM Pi/min. These values and the background values were 
subtracted. 
PTPase activity was also assayed by measuring the hydrolysis of 
pNPP monitoring the absorption changes due to the formation of 
p-nitrophenol. The reaction mixture consisted of 50/d of 10 mM pNPP 
in 1 mM EDTA, 2.5 mM DTT, 0.1% Triton X-100, 50 mM Bis-Tris, 
pH 6.0 and 50/al of fraction and was incubated at 37°C for 30 min. The 
reaction was terminated by the addition of 100/al of NaOH (250 raM). 
The color was measured at 405 nm by an ELISA plate reader. The 
control expressing the basal hydrolysis of the substrate only contained 
the homogenization buffer instead of an eluted fraction sample. 
2.5. fl-Hexoseaminidase ctivity assay 
The secretory response of RBL-2H3 cells was monitored by measur- 
ing the activity of the granule-stored nzyme fl-hexoseaminidase ap- 
pearing in the cells' supernatants a described previously [26]. Briefly, 
cells (20 x 106) were suspended in medium with excess of monoclonal 
DNP-specific IgE (1/al of ascites/106 cells) to saturate the FceRIs and 
were plated in 96-well plates at 2 x 10 s cells/well. On the following day, 
monolayers were washed in Tyrode's buffer and incubated for 45 rain 
at 37"C with a range of different DNPII-BSA concentrations. Follow- 
ing the incubation, 20/al samples of the supernatants were transferred 
to a different plate and 50/al of substrate solution (1.3 mg/ml p-nitro- 
phenyl-N-acetyl-fl-D-glucosamine in 0.1M citrate, pH 4.5) were added. 
The plates were incubated for 1 h at 37"C. The reaction was stopped 
with 150/al of 0.2 M glycine, pH 10.7. The color formed due to the 
substrate hydrolysis was measured at 405 nm in an ELISA plate reader. 
Results are reported as percent of the total fl-hexoseaminidase content 
of the ceils (determined by lysis of control ceils by 1% Triton X-100) 
after subtracting the spontaneous release observed in the absence of 
secretagogue. Each assay was performed in triplicate. 
3. R~ 
3.1. Partial purification of protein tyrosine phosphatases 
of RBL-2H3 cells 
Both cytosolic and membranal fractions of RBL-2H3 
cells were prepared and screened for their PTPase activ- 
ity. To this end, RBL-2H3 cells (3 × l0 s) were harvested, 
homogenized and the homogenate was separated into 
cytosolic and membrane fractions as described above. In 
both fractions, considerable phosphatase activities were 
observed. Both were further characterized following 
anion- exchange chromatography on DE-52 columns 
using step-wise lution with a range of NaC1 concentra- 
tions (0.06 M-0.5 M NaC1 in 0.025 M "Iris, 2% glycerol, 
pH 7.4). In the cytosolic fractions, 3 peaks of activity 
were reproducibly observed (data not shown). Three 
main peaks of activity were resolved in the membranal 
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Fig. 1. Elution profile of PTPase activity: The membranal fraction of 
the cells homogenate was loaded onto a DE-52 column equilibrated in
the homogenization buffer and duted with different NaCI concentra- 
tions (indicated in the figure) in the same buffer. One ml fractions were 
collected. Each fraction was tested for its PTPase activity. Samples from 
two different cell preparations were tested; resting (-II-) and antigen 
stimulated (-I~-). This figure represents a typical elution profile, ob- 
served in more than 7 independent experiments. 
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fraction (Fig. 1), one was observed immediately in the 
run-through of the column, the next peak eluted at 0.06 
M NaC1, and the third eluted at 0.25 M NaC1 concentra- 
tion. Fig. 1 represents a typical elution profile of PTPase 
activity of the membranal fraction that was observed in 
7 independent experiments. 
3.2. Enhancement of PTPase activity upon 
immunological stimulation of RBL-2 H3 cells. 
In order to investigate whether the PTPase activities 
are affected by the Fc,.RI mediated stimulation of the 
RBL-2H3 cells, the cells (3 x 108) were harvested and its 
Fc~RI saturated by incubation with a DNP-specific mon- 
oclonal IgE for 2 h. One portion (1.5 x 108) of the cells 
was then stimulated for 1 min with an optimal dose of 
antigen (100 ng DNPII-BSAJml), while the other portion 
was left as a control. Both cell samples were then sepa- 
rately homogenized, the homogenates were fractionated 
on DE-52 columns and the fractions examined for their 
PTPase activity as described above. Whereas no differ- 
ence could be observed between resting and activated cell 
samples in the three peaks of PTPase activity derived 
from the cytosolic fraction, a significant (up to 3-fold) 
enhancement was observed in the activity of the second 
membranal peak derived from stimulated cells as com- 
pared to that monitored in the same peak derived from 
resting cells (Fig. 1). 
3.3. PTPase activity depends on the degree of 
immunological stimulation 
In order to examine whether the enhancement of the 
PTPase activity correlates with the secretory response to 
immunological stimulation of the cells, antigen dose de- 
pendence of both processes were measured in parallel. 
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Fig. 2. Correlation between the dose-response to antigen stimulation 
of the PTPase activity and mediator elease from RBL-2H3 cells. 
PTPase activity present in peak II of the membranal fraction (-D-) was 
assayed as described with O-phosphotyrosine as a substrate. Mediator 
release (-41-) was assayed by the activity of  secreted fl-hexoseaminidase. 
The measured fl-hexoseaminidase activity is reported as percent of the 
total enzymatic activity content of the cells after subtraction of sponta- 
neous release of the enzyme. 
The PTPase activity of membranal peak II exhibited a
clear dependence on the concentrations of the stimulat- 
ing antigen (Fig. 2). At low antigen concentrations (lng 
DNPI~-BSA/ml) the activity was hardly increased while 
at 10 ng/ml it was already doubled and at 100 ng/ml the 
activity was nearly tripled as compared to that observed 
in this fraction derived from resting cells. These findings 
matched the antigen dose dependence of the secretory 
response as monitored by the secreted activity of the 
granule-stored fl-hexoseaminidase activity (Fig. 2). 
3.4. Dependence of the PTPase activity enhancement on
extracellular Ca e+ ions 
In order to try and localize where in the Fc,RI cou- 
pling cascade the PTPase activity enhancement takes 
place, the stimulation of RBL-2H3 cells was performed 
in the absence of extracellular Ca 2÷. Under such condi- 
tion no elevation of the PTPase activity present in the 
membranal peak II could be observed upon Fc~RI clus- 
tering when compared to that present in the same peak 
obtained from resting cells. 
3.5. Influence of increase in intracellular free Ca 2+ ions 
on PTPase activity 
Since the observed PTPase activity depends on the 
presence of extracellular Ca2÷-ions, we examined 
whether it can be affected by a rise in the concentration 
of free cytosolic Ca2+-ion ([Ca2+]-). We employed two 
reagents known to artificially increase [Ca2÷]i: Thapsi- 
gargin (TG) and ionomycin. The cells were incubated 
with an optimal dose of Thapsigargin (2/.tM) [27] or 
ionomycin (1/tM) for the indicated time periods, were 
then homogenized and fractionated as described above. 
In no case could an increase in the PTPase activity of the 
membranal peak II be observed compared to that activ- 
ity measured in the same peak derived from untreated 
cells. 
3.6. Characterization of the PTPase activity of 
membranal peak H 
3.6.1. Substrate specificity. To further characterize 
the observed PTPase activity present in membranal peak 
II (resting and stimulated), its specificity was studied by 
measuring hydrolysis of other phosphate sters in addi- 
tion to O-phospho-L-tyrosine, namely O-phospho-L- 
threonine, O-phospho-L-serine and p-nitrophenyl phos- 
phate (pNPP). As shown in Fig. 3, neither O-phospho-L- 
threonine nor O-phospho-L-serine were found to un- 
dergo significant hydrolysis above basal levels, while 
both O-phospho-L-tyrosine andp-nitrophenyl phosphate 
were hydrolysed. 
3.6.2. pH dependence of the PTPase activity. The 
PTPase activity of the membranal peak II was assayed 
across the 4.0 to 9.0 pH range. It displays a pH optimum 
ranging from pH 5.0 to pH 6.0, with significant drop of 
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Fig. 3. Characterization f the PTPase activity present in membranal peak II. The right panel shows the substrate specificity of the activity present 
in this peak assayed utilizing the following phosphate esters, O-phosphotyrosine (v rtical stripes), O-phosphoserine (black bars), O-phosphothreonine 
(horizontal stripes) and pNPP (cross-hatched bars). All phosphate esters were tested at a 5 mM concentration i  0.5 M sodium acetate pH 6.0. The 
left panel shows the PTPase activity present in membranal peak II in the presence of each of the two PTPase inhibitors; sodium orthovanadate and 
phenylarsine oxide (PAO). To this end, the samples were incubated as before but in the presence of the respective inhibitor at the indicated 
concentration. For the inhibition studies involving PAO, DTT was omitted from both the control as well as from the sample containing PAO for 
the time of the assay only. Sodium orthovandate: (200gM, black stippled bar; 100 gM, narrow cross-hatch; 10/tM, wide cross-hatch), PAO: (50/tM, 
white bars; 10 gM, light-shaded bars; 1 gM, dark-shaded bars). Control experiments were carried out without additon of any inhibitor (vertical 
stripes). 
activity at pH < 4.5 and practically no activity at pH > 
8.5. 
3.6.3. Kinetics of PTPase activity. We next examined 
whether the PTPase activity of membranal peak II also 
follows Michaelis-Menten kinetics. Hydrolysis of O- 
phosphotyrosine and pNPP was assayed over a range of 
concentrations at pH 6.0. For both substrates, aturation 
kinetics were observed with Km of 10 mM and 6 mM for 
pNPP and O-phosphotyrosine, r spectively. The Vmax 
values were 0.044 gM of released Pi/mg protein x min 
and 0.034 gM of released PJmg protein x min for O- 
phosphotyrosine and pNPP, respectively. 
3.6.4. Effect of PTPase inhibitors. The phosphatase 
activity of membranal peak II was further characterized 
by studies using two widely known PTPase inhibitors, 
vanadate ions and phenyl arsine oxide (PAO): as shown 
in Fig. 3, the PTPase activity present in samples prepared 
from both resting as well as from Fc,RI stimulated cells 
was abolished already by relatively low concentrations 
of vanadate ions (at 10/.tM Vanadate only 33% of activ- 
ity of the stimulated sample and 25% of the resting con- 
trol remained). The other PTPase inhibitor, PAO caused 
only a slight reduction in the activity even at higher 
concentrations (90% of activity at 50 gM PAO for the 
activated sample and 50% at the same concentration for 
the resting control). 
4. Discussion 
Phosphorylation of specific tyrosyl residues of pro- 
teins is a widespread control mechanism employed at 
crucial steps in cellular signal transduction. Thus 
PTPases have a functional role central in the circuitry of 
signalling cascades as for example illustrated by their 
specific regulatory involvement in T-cell activation, 
where the PTPase CD45 is essential [8-10]: CD45 has 
been shown to dephosphorylate the regulatory Tyr 5°5 of 
lck [11], thus activating this src-family member PTK and 
initiating the signalling cascade in T-cells [12]. 
We wish to resolve the role of PTPases in the initial 
phase of Fc,RI stimulus-secretion coupling cascade of 
mast cells. To this end, PTPase activity present in differ- 
ent fractions of the mast cell model system, i.e. the RBL- 
2H3 cell line was investigated in resting and Fc,RI acti- 
vated state. We found that the PTPase activity present 
in one membranal fraction of the activated cells exhibits 
significant elevation compared to that of the same frac- 
tion isolated from resting, control cells. We further ob- 
served that the described PTPase activity is specific to 
aromatic phosphate sters as illustrated by hydrolysis of 
phosphotyrosine and p-nitrophenylphosphate whereas 
no activity towards phosphoserine and phosphothreon- 
ine was observed. Further studies with established inhib- 
itors of alkaline phosphatase (Bromotetramizole) and of 
serine/threonine phosphatase (okadaic acid) were carried 
out and in both cases no inhibition of the phosphatase 
activity of the membranal peak II could be resolved. The 
high Km is probably due to the use of these low molecular 
weight substrates rather than of physiological high mo- 
lecular weight ones. Similar specific activities where ob- 
served for other PTPases [29-32]. 
Two PTPase inhibitors were employed earlier in trying 
to identify the site of action of PTPases in the Fc,RI 
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signal transduction. Adamczewski et al. [33] have de- 
scribed the inhibitory action of PAO on the generation 
of second messengers (e.g. inositol phosphates, Ca 2+ 
ions) and of the eventual secretory response of RBL-2H3 
cells to Fc,RI clustering. Whereas the tyrosine phospho- 
rylation levels of the Fc,RI subunits and of several other 
proteins were found to be unaffected, that of PLCy~ was 
markedly reduced. This was interpreted to suggest that 
at least two distinct PTPases are involved in the Fc,RI 
coupling cascade of these cells, one being PAO sensitive, 
while the other one is not. Zick and Sagi-Eisenberg [34] 
showed that treatment of the same cells with hydrogen- 
peroxide and vanadate ions has quite a different effect. 
Namely, the stimulation of PLCT~ activity and the secre- 
tion of mediators without Fc,RI clustering. Our present 
results show that the Fc,RI mediated enhancement of a 
PTPase activity is strongly inhibited by vanadate ions 
while PAO does not affect it significantly. This inhibition 
pattern suggests that the enhanced PTPase activity might 
be due to one of the enzymes described by Adamczewski 
et al. and by Zick and Sagi-Eisenberg, namely a PAO- 
insensitive and vanadate ion-sensitive activity. 
In order to get an insight in to where this PTPase 
activity is involved in the coupling cascade, we per- 
formed the above described two sets of experiments; first 
the cells were stimulated in the absence of nominal ex- 
tracellular Ca2+-ions and no enhancement was observed. 
Thus extracellular Ca 2÷ is required for the Fc~RI medi- 
ated activity enhancement Second, we examined whether 
an increase in [Ca2+]i, artificially induced by thapsigargin 
or ionomycin, would affect the activity of the isolated 
peak II PTPase. No difference in that activity could be 
resolved by either of the two agents. Thus, elevation of 
[Ca2+]i does not, by itself, activate the PTPase present in 
membranal peak II. Hence the activity enhancement 
could either be initiated upstream to steps causing the 
calcium signal, or the increase in [Ca2+]i alone is not 
sufficient for causing it and other biochemical events 
initiated by the Fc,RI are required for the PTPase activa- 
tion. 
We conclude that the here described PTPase activity 
enhancement is likely to have a control function in the 
Fc,RI signal transduction cascade of RBL-2H3 cells. 
Whether a PTPase causes the activation of the src PTK 
phosphorylation pathway analogous to that described 
for CD45 in T-cells or it is involved in a desensitization 
process requires further studies. 
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